New ruthenium(II) complexes with cyclic thio- and semicarbazone: evaluation of cytotoxicity and effects on cell migration and apoptosis of lung cancer cells

Autor(es):Mostrar menos -

Goncalves, Yasmim G. ; Becceneri, Amanda B. ; Graminha, Angelica E. ; Miranda, Victor M. ; Rios, Rafaella R. ; Rinaldi-Neto, Francisco ; Costa, Monica S. ; Goncalves, Ana C. R. ; Deflon, Victor M. ; Yoneyama, Kelly A. G. ; Maia, Pedro I. S. ; Franca, Eduardo F. ; Cominetti, Marcia R. ; Silva, Roberto S. ; Von Poelhsitz, Gustavo

• Tipo de documento: Artigo Científico
• Fonte: DALTON TRANSACTIONS; v. 52, n. 28, p. 17-pg., 2023-06-22.

Resumo

We describe the synthesis, physicochemical characterization, and in vitro antitumor assays of four novel analogous ruthenium(II) complexes with general formula cis-[Ru-II(N-L)(P-P)(2)]PF6, where P-P = bis(diphenylphosphine)methane (dppm, in complexes 1 and 2) or bis(diphenylphosphine)ethane (dppe, in complexes 3 and 4) and N-L = 5,6-diphenyl-4,5-dihydro-2H-[1,2,4]triazine-3-thione (Btsc, in complexes 1 and 3) or 5,6-diphenyltriazine-3-one (Bsc, in complexes 2 and 4). The data were consistent with cis arrangement of the biphosphine ligands. For the Btsc and Bsc ligands, the data pointed to monoanionic bidentate coordination to ruthenium(II) through N,S and N,O, respectively. Single-crystal X-ray diffraction showed that complex 1 crystallized in the monoclinic system, space group P2(1)/c. Determination of the cytotoxicity profiles of complexes 1-4 gave SI values ranging from 1.19 to 3.50 against the human lung adenocarcinoma cell line A549 and the non-tumor lung cell line MRC-5. Although the molecular docking studies suggested that the interaction between DNA and complex 4 was energetically favorable, the experimental results showed that they interacted weakly. Overall, our results demonstrated that these novel ruthenium(II) complexes have interesting in vitro antitumor potential and this study may contribute to further studies in medicinal inorganic chemistry. (AU)

• Processo FAPESP: 20/03367-6 - Fototerapia utilizando complexos rutênio-ftalocianinas como geradores de espécies reativas de oxigênio e nitrogênio: estudo do mecanismo de ação in vitro em diferentes modelos 2D e 3D de células cancerígenas
• Beneficiário: Amanda Blanque Becceneri
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado